Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Cardiovascular risk factors such as obesity, hypertension and dyslipidaemia are common in patients with diabetes, causing patients to be at increased risk of cardiac events. A number of published studies have found biological mechanisms associated with Diabetes that increase the risk of CVD in diabetic patients. Therefore, targeting CV risk factors in patients with Diabetes is critical to minimise the long-term CV complications associated with diabetes. This session will provide insight into minimising CVD risk in patients with diabetes and effective management in practice

• Explain the relationship between glycaemic control and cardiovascular outcomes, and the importance of reducing cardiovascular risk in people with diabetes
• Awareness of the microvascular and macrovascular outcomes from the ACCORD, ADVANCE, DCCT, UKPDS and VADT studies
• Assess patients with diabetes and CVD risk to identify and, where possible, reduce cardiovascular risk
• Summarise the main cardiovascular outcome data for clinical trials of DPP-4 inhibitors, SGLT-2 inhibitors and GLP-1 receptor agonists